The Norwegian study on District treatment of ST-elevation myocardial infarction (NORDISTEMI)

Scandinavian Cardiovascular Journal

Volumn 41, Issue 1, 2007, Pages 32-38

  Bøhmer, Ellen ^a   Arnesen, Harald ^a   Abdelnoor, Michael ^a   Mangschau, Arild ^a   Hoffmann, Pavel ^a   Halvorsen, Sigrun ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angioplasty; Health economics; Long distance; Myocardial infarction; Prehospital treatment; Quality of life; Randomized controlled trial; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; TENECTEPLASE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HUMAN; INCIDENCE; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; OPEN STUDY; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; ST SEGMENT ELEVATION; THERAPY DELAY;

EID: 33847143675     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430601153472     Document Type: Article

References (25)

1. Van de Werf, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KAA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2003;24:28-66.
2. Huber K, De Caterina R, Kristensen SD, Verheugt FWA, Montalescot G, Badimon M, et al. Pre-hospital reperfusion therapy: A strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J. 2005;26:2063-74.
3. Bassand J-P, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, et al. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J. 2005;26:2733-41.
4. Morrison LJ, Verbeek PR, McDonald AC, Sawasky BV, Cook DJ. Mortality and pre-hospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA. 2000;283:2686-92.
5. Bonnefoy E, Lapostelle F, Leizorovicz A, Steg G, Mc Fadden EP, Dubien PY, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomised study. Lancet. 2002;360:825-9.
6. Björklund E, Stenestrand U, Lindbäck J, Svensson L, Wallentin L, Lindadl B. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J. 2006;27:1146-52.
7. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
8. Danchin N. Should intravenous thrombolysis keep a place in the treatment of acute ST-elevation myocardial infarction? Eur Heart J. 2006;27:1131-3.
9. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-82.
10. Gerschlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;252:2758-68.
11. Madsen JK, Grande P, Saunamaki K, Thayssen P, Kassis E, Eriksen U, et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation, 1997;96:748-55.
12. Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, Vázquez N, Blanco J, Alonso-Briales J, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): A randomised controlled trial. Lancet. 2004;364:1045-53.
13. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, et al. Combined angioplasty and pharmalogical intervention versus thrombolysis alone in acute myocardial infarction. J Am Coll Cardiol. 2005;46:417-24.
14. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 2003;42:634-41.
15. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamn C, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804-47.
16. ASSENT 3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab or unfractioned heparin: the ASSENT 3 randomized trial in acute myocardial infarction. Lancet. 2001;358:605-13.
17. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-89.
18. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT- 4 PCI) Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT- 4 PCI): Randomised trial. Lancet. 2006;367:569-78.
19. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med. 1994;35:594-600.
20. Sintonen H. The 15D instrument of health-related quality of life: Properties and applications. Ann Med. 2001;33:328-36.
21. Ware JE. SF-36 health survey manual and interpretation guide. Boston MA: The Health Institute; 1993.
22. Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data, quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol. 1998;51:1069-76.
23. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733-42.
24. Di Mario C, Bolognese L, Maillard L, Dudek D, Gambarat G, Manari A, et al. Combined Abciximab REteplase Stent Study in Acute myocardial Infarction (CARESS in AMI). Am Heart J. 2004;148:378-85.
25. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Effect of clopidogrel pre-treatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: The PCI-CLARITY study. JAMA. 2005;294: 1271-3.